How to assess kidney outcomes in obese people with substantial weight loss: the case of GLP1- and dual-receptor agonists. | Nephrol Dial Transplant;39(7): 1060-1062, 2024 Jun 28. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

How to assess kidney outcomes in obese people with substantial weight loss: the case of GLP1- and dual-receptor agonists.

Rothberg, Amy E; Herman, William H.

Affiliation

Rothberg AE; Internal Medicine and Nutritional Sciences, University of Michigan, Ann Arbor, MI, USA.
Herman WH; Internal Medicine and Epidemiology, University of Michigan, Ann Arbor, MI, USA.

Nephrol Dial Transplant ; 39(7): 1060-1062, 2024 Jun 28.

Article in En | MEDLINE | ID: mdl-38299776

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Weight Loss / Obesity Limits: Humans Language: En Journal: Nephrol Dial Transplant Journal subject: NEFROLOGIA / TRANSPLANTE Year: 2024 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Weight Loss / Obesity Limits: Humans Language: En Journal: Nephrol Dial Transplant Journal subject: NEFROLOGIA / TRANSPLANTE Year: 2024 Document type: Article Affiliation country: Country of publication: